These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11988628)

  • 1. Falls, fractures, and osteoporosis after stroke: time to think about protection?
    Poole KE; Reeve J; Warburton EA
    Stroke; 2002 May; 33(5):1432-6. PubMed ID: 11988628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hip fractures after stroke and their prevention.
    Myint PK; Poole KE; Warburton EA
    QJM; 2007 Sep; 100(9):539-45. PubMed ID: 17693418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and prevention of osteoporosis-related fractures.
    Dontas IA; Yiannakopoulos CK
    J Musculoskelet Neuronal Interact; 2007; 7(3):268-72. PubMed ID: 17947811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risedronate therapy for prevention of hip fracture after stroke in elderly women.
    Sato Y; Iwamoto J; Kanoko T; Satoh K
    Neurology; 2005 Mar; 64(5):811-6. PubMed ID: 15753414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone fractures in oldest olds in nursing house].
    Morimoto S; Takamoto S
    Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):48-51. PubMed ID: 16521800
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
    Miller PD
    Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated approach: bisphosphonate management for the treatment of osteoporosis.
    Owens G; Jackson R; Lewiecki EM
    Am J Manag Care; 2007 Dec; 13 Suppl 11():S290-308; quiz S309-12. PubMed ID: 18095779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of hip fractures and methods of prevention.
    Armstrong AL; Wallace WA
    Acta Orthop Belg; 1994; 60 Suppl 1():85-101. PubMed ID: 8053345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehabilitation after falls and fractures.
    Dionyssiotis Y; Dontas IA; Economopoulos D; Lyritis GP
    J Musculoskelet Neuronal Interact; 2008; 8(3):244-50. PubMed ID: 18799857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of medication reviews performed by a physician on treatment with fracture-preventing and fall-risk-increasing drugs in older adults with hip fracture-a randomized controlled study.
    Sjöberg C; Wallerstedt SM
    J Am Geriatr Soc; 2013 Sep; 61(9):1464-72. PubMed ID: 24028354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing hip fracture after stroke.
    Bast BA; Greenwald BD
    Top Stroke Rehabil; 2007; 14(4):67-79. PubMed ID: 17698459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of osteoporosis: strategies for individualized treatment].
    Weber K; Hoffmann A; Leb G
    Wien Med Wochenschr; 1999; 149(16-17):489-92. PubMed ID: 10627987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.
    Sato Y; Iwamoto J; Kanoko T; Satoh K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1743-8. PubMed ID: 16087822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hip fractures: medical and nonmedical management.
    Lin JT; Lane JM
    Instr Course Lect; 2004; 53():417-25. PubMed ID: 15116631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].
    Leszczyński P
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(3):168-71. PubMed ID: 21038635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.